Followers | 3350 |
Posts | 85998 |
Boards Moderated | 5 |
Alias Born | 10/05/2005 |
Sunday, May 26, 2019 9:56:12 PM
By Denise Gardner - May 24, 2019
5 analysts out of 8 Wall Street brokerage firms rate Novavax, Inc. (NASDAQ:NVAX) as a Buy, while 1 see it as a Sell. The rest 2 describe it as a Hold. NVAX stock traded higher to an intra-day high of $6.17. At one point in session, its potential discontinued and the price was down to lows at $5.8982. Analysts have set NVAX’s consensus price at $25.14, effectively giving it a 310.78% projection on returns. Should the projected estimates be met, then the stock will likely hit its highest price at $40 (up 553.59% from current price levels). NVAX has a 136.3% ROE, higher than the 10.05% average for the industry. The average ROE for the sector is 15.24%.
It is expected that in Jun 2019 quarter NVAX will have an EPS of $-1.88, suggesting a 21.67% growth. For Sep 2019 is projected at $-1.65. It means that there could be a 31.25% growth in the quarter. Yearly earnings are expected to rise by 30.6% to about $-6.94. As for the coming year, growth will be about 21.9%, lifting earnings to $-5.42. RSI after the last trading period was 32.43. NVAX recorded a change of -4.82% over the past week and returned -84.06% over the last three months while the NVAX stock’s monthly performance revealed a shift in price of -40.16%. The year to date (YTD) performance stands at -83.37%, and the bi-yearly performance specified an activity trend of -82.21% while the shares have moved -81.89% for the past 12 months.
Novavax, Inc. (NVAX) currently trades at $6.12, which is higher by 1.16% its previous price. It has a total of 25.58 million outstanding shares, with an ATR of around 0.69. The company’s stock volume dropped to 0.7 million, worse than 1.12 million that represents its 50-day average. A 5-day decrease of about -4.82% in its price means NVAX is now -83.37% lower on year-to-date. The shares have surrendered $43591.88 since its $51.60 52-week high price recorded on 13th of December 2018. Overall, it has seen a growth rate of -81.89 over the last 12 months. The current price per share is $0.4 above the 52 week low of $5.72 set on 13th of May 2019.
Novavax, Inc. (NASDAQ:NVAX)’s EPS was $-2.2 as reported for the March quarter. In comparison, the same quarter a year ago had an EPS of $-2.8. That means that its growth in general now stands at -21%. Therefore, a prediction of $-2.21 given by the analysts brought a negative surprise of 0%. NVAX March quarter revenue was $3.98 million, compared to $9.65 million recorded in same quarter last year, giving it a -59% growth rate. The company’s $-5.67 million revenue decline that quarter surprised Wall Street and investors will need to consider this as they assess the stock.
Brookfield Property Partners L.P. (NASDAQ:BPY) shares depreciated -1.56% over the last trading period, taking overall 5-day performance up to -2.05%. BPY’s price now at $19.57 is weaker than the 50-day average of $20.48. Getting the trading period increased to 200 days, the stock price was seen at $19.25 on average. The general public currently hold control of a total of 17.06 million shares, which is the number publicly available for trading. The total of shares that it has issued to investors is 429.16 million. The company’s management holds a total of 0.85%, while institutional investors hold about 67% of the remaining shares. BPY share price finished last trade -3.69% below its 20 day simple moving average and its upbeat gap from 200 day simple moving average is 1.64%, while closing the session with -4.47% distance from 50 day simple moving average.
Brookfield Property Partners L.P. (BPY) shares were last observed trading -7.78% down since April 11, 2019 when the peak of $21.22 was hit. Last month’s price growth of -5.78% puts BPY performance for the year now at 21.4%. Consequently, the shares price is trending higher by 30.82%, a 52-week worst price since Dec. 26, 2018. However, it is regaining value with 6.82% in the last 6 months.
The firm’s current profit margin over the past 12 months is 10.4%. BPY ranks lower in comparison to an average of 25.39% for industry peers; while the average for the sector is 29.43%.
Lets exchange member marks and exchange market moving information today!
All my posts are strictly my opinion only! Please do your own DD.
Recent NVAX News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:08:16 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. • PR Newswire (US) • 09/13/2024 01:25:00 PM
- Novavax to Participate in Upcoming September Conferences • PR Newswire (US) • 09/04/2024 01:25:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 08:19:00 PM
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. • PR Newswire (US) • 08/30/2024 07:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:47:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:06:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:04:56 PM
- Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights • PR Newswire (US) • 08/08/2024 12:02:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:37:07 AM
- U.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices Stall • IH Market News • 08/08/2024 09:55:44 AM
- Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024 • PR Newswire (US) • 08/01/2024 01:25:00 PM
- ASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and More • IH Market News • 07/31/2024 09:55:50 AM
- Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine • PR Newswire (Canada) • 07/02/2024 12:30:00 PM
- Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine • PR Newswire (US) • 06/24/2024 01:18:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 08:09:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/17/2024 08:13:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:14:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:11:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:10:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:07:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:06:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:05:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 08:01:29 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM